MIFLONIDE

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Germany, Israel, Poland, Spain, Tunisia.

Active ingredients

The drug MIFLONIDE contains one active pharmaceutical ingredient (API):

1	Budesonide UNII Q3OKS62Q6X - BUDESONIDE
	Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.
	Read more about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	526510601117416, 526510602113414, 526520110096407
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09290063, 09290152, 11862035, 11862041, 11862058, 11862064, 14341549, 14372343, 14398911, 15584633
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.088-04-03
EE	Ravimiamet	1124390, 1124413
ES	Centro de información online de medicamentos de la AEMPS	63197, 63198
IL	מִשְׂרַד הַבְּרִיאוּת	4525, 4526
PL	Rejestru Produktów Leczniczych	100106959, 100106965
TN	Direction de la Pharmacie et du Médicament	10283141, 10283142